Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GLPG | NASDAQ | USD | Real-time | |
GLPGa | BATS Europe | EUR | Delayed | |
GLPGF | OTC Markets | USD | Delayed | |
GLPG | TradeGate | EUR | Delayed | |
GLPG | Amsterdam | EUR | Real-time | |
GLPG | Vienna | EUR | Real-time |
On Wednesday, Kepler Cheuvreux adjusted its stance on biotechnology firm Galapagos (AS:GLPG) NV (NASDAQ:GLPG:NA) (NASDAQ: GLPG), downgrading the stock from Hold to Reduce. The...
On Monday, Deutsche Bank adjusted its price target on Galapagos NV (NASDAQ:GLPG:NA) (NASDAQ: GLPG), reducing it to €28 from the previous €30, while continuing to...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy | Buy | Sell |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Completed Patterns | |||||
Three Inside Up | 1H | 2 | Dec 03, 2024 02:00 | ||
Two Crows | 1D | 3 | Nov 26, 2024 | ||
Dark Cloud Cover | 15 | 4 | Dec 03, 2024 03:45 | ||
Bullish Engulfing | 1H | 5 | Dec 02, 2024 23:00 | ||
Engulfing Bearish | 1H | 6 | Dec 02, 2024 22:00 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
NASDAQ | 27.99 | 0.00 | 0.00 | 110,510 | +1.27% | USD | 04:59:59 | ||
BATS Europe | 26.22 | 26.26 | 25.96 | 0 | 0.00% | EUR | 30/11 | ||
OTC Markets | 26.26 | 0.00 | 0.00 | 0 | 0.00% | USD | 26/11 | ||
TradeGate | 26.62 | 26.60 | 26.66 | 100 | +0.68% | EUR | 20:51:13 | ||
Amsterdam | 26.62 | 0.00 | 0.00 | 14,155 | +0.91% | EUR | 21:30:54 | ||
Vienna | 26.44 | 26.40 | 26.88 | 0 | 0.00% | EUR | 00:35:59 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Dito CME Holdings | 1.8000 | 1.8300 | 1.6300 | +0.2300 | +14.65% | 49.48M | 14:57:35 | ||
Bank of the Philippine Islands | 127.70 | 129.40 | 127.70 | +1.28 | +1.01% | 4.47M | 14:58:40 | ||
Universal Robina | 78.00 | 78.80 | 77.25 | +0.70 | +0.91% | 1.47M | 14:54:03 | ||
LT Group | 10.080 | 10.140 | 10.080 | -0.040 | -0.40% | 1.89M | 14:53:08 | ||
PLDT | 1,360.00 | 1,365.00 | 1,341.00 | +18.00 | +1.34% | 131.76K | 14:55:26 | ||
DigiPlus Interactive | 23.600 | 23.750 | 23.100 | +0.550 | +2.39% | 7.37M | 14:58:32 | ||
RFM | 3.900 | 3.950 | 3.870 | +0.030 | +0.78% | 292.00K | 14:54:56 | ||
Semirara Mining | 32.30 | 32.40 | 31.95 | +0.35 | +1.10% | 1.67M | 14:58:12 | ||
Ayala Land | 29.150 | 29.300 | 28.650 | +0.150 | +0.52% | 11.94M | 14:58:17 | ||
International Container | 394.000 | 396.600 | 385.000 | +4.000 | +1.03% | 1.97M | 14:54:23 |
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review